Remdesivir Global Market To Grow At Rate Of 31% Through 2026

The Business Research Company’s Remdesivir Global Market Report 2022: Market Size, Trends, And Forecast To 2026

LONDON, GREATER LONDON, UK, June 6, 2022 /EINPresswire.com/ — According to ‘Remdesivir Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026’ published by The Business Research Company, the global remdesivir market is expected to reach $11.17 billion in 2026 at a CAGR of 31.2%. Increasing prevalence of COVID-19 disease globally is a key factor driving the remdesivir market growth.

Want to learn more on the remdesivir market growth? Request for a Sample now.

The remdesivir market consists of sales of remdesivir drugs currently found effective in treating the COVID-19 disease. Remdesivir (RDV) is one of the promising drugs used currently for the treatment of the COVID-19 disease. Gilead, the US drug manufacturer is expanding its Remdesivir production due to the high demand for this drug. RDV is a synthetic compound throughout the class of antiviral drugs that target RNA synthesis.

Global Remdesivir Market Trends
Gilead licensed remdesivir for COVID-19 to companies manufacturing generic drugs for sale in 127 countries. Five generic companies Cipla, Ferozsons Labs, Hetero Labs, Jubilant Lifesciences and Mylan will have the right to manufacture and sell generic versions of the drug in mostly lower-income countries, as well as higher-income countries that face significant obstacles to healthcare access. The licensees won’t pay royalties to Gilead until the pandemic is called off or until a second drug is approved. This is likely to challenge the growth of the market.

Global Remdesivir Market Segments
The global remdesivir market is segmented:
By Route of Administration: Oral, Intravenous
By Dosage Form: Tablets, Frozen Solution, Lypholized Solution
By Distribution Channel: Hospitals, Clinics, Drug Stores/Pharmacies, Online, Others
By Geography: The global remdesivir market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America accounts for the largest share.

Read more on the global remdesivir market report here

Remdesivir Global Market Report 2022 is one of a series of new reports from The Business Research Company that provides remdesivir market overviews, analyzes and forecasts market size and growth for the global remdesivir market, remdesivir global market share, remdesivir global market segments and geographies, remdesivir market players, remdesivir market leading competitor revenues, profiles and market shares. The remdesivir market report identifies top countries and segments for opportunities and strategies based on market trends and key competitors’ approaches.

TBRC’s Remdesivir Global Market Report 2022 includes information on the following:

Data Segmentations: Market Size, Global, By Region and Country, Historic and Forecast, and Growth Rates for 60 Geographies

Key Market Players: Gilead Sciences Inc., Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Cipla, Pfizer, Merck, Cayman Chemical, and Dr. Reddy’s Laboratories.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
And so much more.

Looking for something else? Here is a list of similar reports by The Business Research Company:
Anti-Viral Drug Therapy Market – By Drug Class (DNA (Nucleotide) Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Application (HIV, Hepatitis, Herpes, Influenza), Anti-Viral Drug Therapy Market Size, Opportunities And Strategies – Global Anti-Viral Drug Therapy Market Forecast To 2030

COVID-19 Rapid Test Kits Global Market Report 2022 – By Test Type (Rapid Antigen Test, Rapid Antibody Test, Other Test Types), By Kit Type (Equipment and Extraction Kits, rRT-PCR Test Kits, Reagents), By Specimen Type (Nasopharyngeal swab, Oropharyngeal swab, Nasal swab, Other Specimen Types), By End-Users (Hospitals and Clinics, Diagnostic laboratories, Home Care, Other End-Users) – Market Size, Trends, And Global Forecast 2022-2026

Anti-Infective Drugs Global Market Report 2022 – By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Check out our:
LinkedIn: https://bit.ly/3b7850r
Twitter: https://bit.ly/3b1rmjS
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn